NCT
Heidelberg Cancer Collaboration Enables Targeted and Comprehensive Molecular Tumor Profiling
Premium
A partnership involving Heidelberg University Hospital, the National Center for Tumor Diseases, and the German Cancer Research Institute is serving patients across Germany.
Q&A: NCT's Christof von Kalle on Introducing 'Molecular Imaging' of Cancer Genomes for Patients
Premium
Name: Christof von Kalle
Age: 49
German Researchers Use $10.1M to Investigate Early Prostate Cancer
The tumor cell genome of 250 prostate cancer patients ages 50 and younger will be compared with gene sequences from healthy cells to uncover gene mutations that can cause and promote prostate cancer, and ultimately to create a map of all genetic modifications involving prostate cancer.